Journal article
2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?
Current Atherosclerosis Reports, Vol.16(6), pp.1-6
06/2014
DOI: 10.1007/s11883-014-0413-5
PMID: 24671669
Abstract
In November 2013, the American College of Cardiology and American Heart Association (ACC/AHA) released a clinical practice guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk in adults. The guideline recommendations were developed from a rigorous systematic review of randomized, controlled trials (RCTs) and meta-analyses of RCTs that evaluated ASCVD outcomes. Major recommendations address a healthy lifestyle, identification of groups of patients most likely to experience a net benefit form statin therapy, appropriate intensity of statin therapy to reduce ASCVD, safety, decision-making in primary prevention, monitoring therapy, and appropriate use of nonstatin therapy. Areas of controversy are discussed.
Details
- Title: Subtitle
- 2013 ACC/AHA Cholesterol Guideline for Reducing Cardiovascular Risk: What is so Controversial?
- Creators
- Jennifer Robinson - Departments of Epidemiology & Medicine University of Iowa 145 N Riverside Drive S455 CPHB Iowa City IA 52242 USA
- Resource Type
- Journal article
- Publication Details
- Current Atherosclerosis Reports, Vol.16(6), pp.1-6
- Publisher
- Springer US; Boston
- DOI
- 10.1007/s11883-014-0413-5
- PMID
- 24671669
- ISSN
- 1523-3804
- eISSN
- 1534-6242
- Language
- English
- Date published
- 06/2014
- Academic Unit
- Epidemiology; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
- Record Identifier
- 9983995179602771
Metrics
29 Record Views